Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises in connection with the acquisition of Domtar’s Personal Care business
Mandate

Vinge advises in connection with the acquisition of Domtar’s Personal Care business

January 14, 2021 Employment and Benefits Corporate Crime & Compliance M&A Real Estate and Construction Commercial Agreements

Acting as a Swedish local counsel, Vinge has together with Ropes & Gray LLP and Baker Botts LLP advised American Industrial Partners in connection with the acquisition of the Domtar Personal Care business for $920 million, subject to customary adjustments.

Domtar is a leading manufacturer and provider of a wide variety of fiber-based products including market pulp and absorbent hygiene products. Domtar has approximately 8,800 employees and serves more than 50 countries. American Industrial Partners is a private equity firm that focuses on buying and improving industrial businesses with operations in the United States or Canada. You can read the press release from Domtar’s Personal Care business here.

Vinge’s team consisted of, among others, Christina Kokko, Ulrich Ziche, Vilhelm Rondahl and Olivia Belding (M&A), Lova Unge (Commercial Agreements), Karin Gynnerstedt (Employment), Karolina Fuhrman, Lina Österberg and Frida Ställborn (Real Estate and Environment), as well as Nathalie Hughes (VDR assistant).

 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025